Skip to main content
. 2022 Sep 2;12:14971. doi: 10.1038/s41598-022-18977-0

Table 3.

CA/09-like virus-infection induced focused HAI antibody responses.

Patient Sera HAIa Fold reductionb Focused HAI antibody responses
CA/09 MX/09 X-179A RG RG RG X-179A RG RG RG
No. (#) dpo dpicu wt Q223QR Q223R K163Q 127gly 130del Q223R K163Q 127gly 130del
#1* 8 2 2560 40 <  1280 2560 80 256 32 K130, Q223
14 8 160 40 40 <  160 160 4 16 K163, Q223
28 22 2560 2560 640 160 2560 2560 4 16 K163, Q223
#2* 3 3 2560 160 80 2560 2560 160 32 16 K130, Q223
4 4 2560 160 80 2560 2560 160 32 16 K130, Q223
#3 18 1 1280 1280 1280 1280 1280 160 8 K130
35 18 1280 1280 1280 1280 1280 160 8 K130
41 24 1280 1280 1280 1280 1280 160 8 K130
#4 13 7 640 320 640 320 40 40 16 16 127gly, K130
16 10 1280 1280 1280 1280 160 160 8 8 127gly, K130
28 22 1280 1280 1280 1280 160 160 8 8 127gly, K130
#5 18 2 320 320 320 320 80 160 4 127gly
45 29 640 640 640 640 80 160 8 4 127gly, K130
#6 8 1 320 320 80 320 320 80 4 4 K130, Q223
11 4 1280 640 320 1280 1280 320 4 4 K130, Q223
14 7 2560 2560 640 1280 1280 640 4 4 K130, Q223
#7 3 2 320 160 160 320 160 320 ND¥
22 21 12,800 12,800 12,800 12,800 12,800 12,800 ND
#8 9 2 160 160 80 40 80 160 4 K163
14 7 5120 2560 5120 1280 5120 5120 4 K163
#9 13 2 80 80 40 80 80 40 ND
15 4 320 320 320 320 320 160 ND
#10 9 2 80 80 80 80 <  <  8 8 127gly, K130
14 7 640 1280 1280 640 80 80 8 8 127gly, K130
18 11 1280 1280 1280 1280 160 160 8 8 127gly, K130
#11* 9 2 80 80 80 80 80 <  16 K130
#12 5 1 80 40 40 80 20 80 4 127gly
7 3 160 160 80 320 40 320 4 127gly
14 10 640 320 160 640 80 640 4 8 127gly, Q223
#13 25 5 80 80 80 20 80 80 4 K163
30 10 320 320 320 40 320 320 8 K163
40 20 640 640 640 80 640 640 8 K163
#14 2 2 80 40 20 80 80 20 4 4 K130, Q223
4 4 1280 160 20 1280 1280 40 64 32 K130, Q223
10 10 1280 80 40 1280 1280 40 32 32 K130, Q223
#15 13 8 320 320 320 320 80 160 4 127gly
27 22 640 640 640 640 80 160 8 4 127gly, K130
#16 8 3 320 160 160 160 160 160 ND
12 7 640 640 640 640 640 640 ND
#17 9 5 80 80 80 80 40 20 4 K130
11 7 320 320 320 320 160 40 8 K130
19 15 320 320 320 320 160 40 8 K130
#18 8 4 160 160 160 160 160 160 ND
34 30 2560 1280 1280 1280 1280 1280 ND
#22 20 6 320 320 160 160 160 320 ND
36 22 640 640 640 640 320 640 ND
#23 15 7 640 640 320 640 80 640 8 127gly
22 14 1280 1280 1280 1280 160 1280 8 127gly
29 21 1280 1280 1280 1280 320 1280 4 127gly
#24 11 4 160 80 160 160 40 20 4 8 127gly, K130
13 6 640 1280 640 640 160 40 4 16 127gly, K130
27 20 2560 2560 2560 2560 640 160 4 16 127gly, K130
#25* 13 7 5120 640 320 5120 5120 640 16 8 K130, Q223
#26 12 6 80 160 160 160 160 80 ND
21 15 640 640 640 640 640 320 ND
#27 7 6 160 160 160 20 160 160 8 K163
23 22 320 160 320 40 320 320 8 K163
#29 10 7 320 320 160 80 160 160 4 K163
16 13 1280 1280 640 320 640 640 4 K163
#31 17 14 320 320 320 320 160 160 ND
24 21 320 320 320 320 160 160 ND

dpo, days post-symptom onset; dpicu, days post ICU admission; –, ≤ twofold reductions; ¥ND, not detected.

*Fatal patients in bold. For each sample, we completed three independent HAI assays.

aSera from 26 patients possessing HAI titers of ≥ 80 against wt-CA/09 were tested by HAI assays with the 6 viruses.

bFold reduction of HAI titers against virus-mutant(s) compared to wt-CA/09.